The Risk for Prostate Cancer With Calcium Channel Blockers: A Systematic Review, Meta-Analysis, and Meta-Regression.
- Published in:
- Annals of Pharmacotherapy, 2023, v. 57, n. 1, p. 16, doi. 10.1177/10600280221098121
- By:
- Publication type:
- Article
Works matching IS 10600280 AND DT 2023 AND VI 57 AND IP 1
Results: 14
1
2
Hyperglycemia Post-Influenza Vaccine in Patients With Diabetes.
- Published in:
- Annals of Pharmacotherapy, 2023, v. 57, n. 1, p. 51, doi. 10.1177/10600280221098101
- By:
- Publication type:
- Article
3
Considerations When Using Body Mass Index as a Size Descriptor.
- Published in:
- Annals of Pharmacotherapy, 2023, v. 57, n. 1, p. 107, doi. 10.1177/10600280221097968
- By:
- Publication type:
- Article
4
Comparison of Two-Bag Versus Three-Bag N-Acetylcysteine Regimens for Pediatric Acetaminophen Toxicity.
- Published in:
- Annals of Pharmacotherapy, 2023, v. 57, n. 1, p. 36, doi. 10.1177/10600280221097700
- By:
- Publication type:
- Article
5
Successful Desensitization to Remdesivir Hypersensitivity in a Patient Undergoing Treatment for COVID-19.
- Published in:
- Annals of Pharmacotherapy, 2023, v. 57, n. 1, p. 110, doi. 10.1177/10600280221096883
- By:
- Publication type:
- Article
6
Abrocitinib: A New FDA-Approved Drug for Moderate-to-Severe Atopic Dermatitis.
- Published in:
- Annals of Pharmacotherapy, 2023, v. 57, n. 1, p. 86, doi. 10.1177/10600280221096713
- By:
- Publication type:
- Article
7
Relationship Between Mean Arterial Pressure and Furosemide Stress Test Success Rates: A Retrospective Cohort Study.
- Published in:
- Annals of Pharmacotherapy, 2023, v. 57, n. 1, p. 44, doi. 10.1177/10600280221096466
- By:
- Publication type:
- Article
8
Tezepelumab in the Treatment of Uncontrolled Severe Asthma.
- Published in:
- Annals of Pharmacotherapy, 2023, v. 57, n. 1, p. 62, doi. 10.1177/10600280221095540
- By:
- Publication type:
- Article
9
The Use of High-Dose Corticosteroids Versus Low-Dose Corticosteroids With and Without Tocilizumab in COVID-19 Acute Respiratory Distress Syndrome.
- Published in:
- Annals of Pharmacotherapy, 2023, v. 57, n. 1, p. 5, doi. 10.1177/10600280221094571
- By:
- Publication type:
- Article
10
Outcomes of a Undiluted, One-Bag Desensitization Protocol for Chemotherapeutic Agents.
- Published in:
- Annals of Pharmacotherapy, 2023, v. 57, n. 1, p. 55, doi. 10.1177/10600280221093594
- By:
- Publication type:
- Article
11
Comment: Pharmacists Have the Stats but No Provider Status—Now May Be Our Moment.
- Published in:
- Annals of Pharmacotherapy, 2023, v. 57, n. 1, p. 113, doi. 10.1177/10600280221088002
- By:
- Publication type:
- Article
12
Estimation of Kidney Function in Patients With Multiple Myeloma: Implications for Lenalidomide Dosing.
- Published in:
- Annals of Pharmacotherapy, 2023, v. 57, n. 1, p. 29, doi. 10.1177/10600280221087218
- By:
- Publication type:
- Article
13
Bupivacaine/meloxicam ER: A New Dual-acting Extended-Release Local Anesthetic for Opioid-Sparing Postoperative Pain Management.
- Published in:
- Annals of Pharmacotherapy, 2023, v. 57, n. 1, p. 71, doi. 10.1177/10600280221086639
- By:
- Publication type:
- Article
14
Ibrexafungerp in the Treatment of Vulvovaginal Candidiasis.
- Published in:
- Annals of Pharmacotherapy, 2023, v. 57, n. 1, p. 99, doi. 10.1177/10600280221091301
- By:
- Publication type:
- Article